Search Results
Search results for "Jana Selent"
Results found for "Jana Selent"
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
with Regeneron Pharmaceuticals, Inc. whereby Confo’s technology platform, which uses conformationally selective
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
While more work is needed to further elucidate the translational value of selectively targeting CB2 receptors
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
consisting of approximately 850 GPCRs) has been successfully drugged, and obtaining highly potent and selective
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
from its Phase 3 KINECT-HD study evaluating the efficacy, safety and tolerability of valbenazine, a selective
- Discovery of 3(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligand
Moreover, compounds 6c and 6e showed a significant selectivity over S2R.
- đź“° GPCR Weekly News, March 13 to 19, 2023
Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide Structural and Molecular Insights into GPCR Function Structural basis of selective cannabinoid CB2 receptor
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
interactions with ligands and the cellular environment which are crucial for understanding how drugs can selectively
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Among the top-ranked compounds, 59 fragments and 59 lead-like compounds were selected for experimental
- đź“° GPCR Weekly News, February 20 to 26, 2023
GPCR Activation and Signaling Coupling between GPR143 and dopamine D2 receptor is required for selective D2 receptor ligand binding and signaling GPCR Binders, Drugs, and more Discovery of the Potent and Selective
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Among the top-ranked compounds, 59 fragments and 59 lead-like compounds were selected for experimental
- Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European ...
opinion recommending marketing authorization for the Company’s TAVNEOS (avacopan), an orally administered selective
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
called promising candidates in G protein-coupled receptor (GPCR) drug development by displaying subtype selectivity
- Cell-Type-Specific Effects of the Ovarian Cancer G-Protein Coupled Receptor (OGR1) on Inflammation..
Our results suggest that strategies to selectively target OGR1 expression may represent a novel therapeutic
- From Pipettes to Platforms: The Evolution of GPCR Research
a starting point for more ambitious questions about GPCR networks, biased signaling, and functional selectivity
- Molecular creativity in drug discovery
And that matter shapes everything: selectivity, safety, efficacy, and innovation.
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
ADX71149 is a selective metabotropic glutamate type 2 (mGlu2) receptor positive allosteric modulator
- Precise druggability of the PTH type 1 receptor
modulates the collective dynamics of the receptor and used this ensemble of PTHR conformers to identify selective
- Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C...
available to study the contribution of PKC isozymes have considerable limitations, including a lack of selectivity
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Pc(4-4), a lead backbone cyclic peptide, was selected out of a mini-library, directed toward PAR2&4 PH-binding
- G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease..
protein-biased GPR3 mouse model to investigate the physiological and pathophysiological consequences of selective
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
mechanistic insights of our study provide clues for the future design of isoform-specific GPR35 ligands that selectively
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Yamina’s Corner reveals how fragmented data, undefined workflows, and ambiguous decision gates silently
- Why “Displacement” Misleads You: Allosteric Binding Demystified
If your project involves GPCRs , functional selectivity , or non-traditional ligands , this session is
- Biphasic activation of β-arrestin 1 upon interaction with a GPCR revealed by methyl-TROSY NMR
The conformation-selective antibody, Fab30, promotes partially activated βarr into the activated-like
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Platform selection shapes interpretation. Infrastructure influences velocity. Â
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Highly selective filters can streamline resource allocation Early elimination of unsafe scaffolds prevents
- đź“° GPCR Weekly News, January 30 to February 5, 2023
Cannabinoid 1 (CB1 ) receptor arrestin subtype-selectivity and phosphorylation dependence. GPCR Binders, Drugs, and more Ligands selectively tune the local and global motions of neurotensin receptor
- đź“° GPCR Weekly News
targets Constitutive activity of the dopamine receptor D5R, highly expressed in CA1 hippocampal neurons, selectively
- đź“° GPCR Weekly News, July 3 to 9, 2023
GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
From t-test, ANOVA, F-test selection to power analysis  that prevents underpowered studies, this module








